Abstract
Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of subacute, chronic or acute systemic immune-mediated diseases of the skeletal muscles. Recently, research has shown the utility of adding new classifications of myopathies, mainly based on their pathology and the presence of specific autoantibodies. In addition, developments in genetics have helped reveal the genetic background of IIM. The human leukocyte antigen genomic region has been consistently shown to be the strongest genetic risk factor for IIM. The present review summarizes the previous and current literature on human leukocyte antigen analysis of IIM, as well as future directions for research.
| Original language | English |
|---|---|
| Journal | Clinical and Experimental Neuroimmunology |
| DOIs | |
| Publication status | Accepted/In press - 2017 |
Keywords
- Human leukocyte antigen
- Idiopathic inflammatory myopathy
- Myositis-specific autoantibodies
ASJC Scopus subject areas
- Neuroscience (miscellaneous)
- Immunology
- Immunology and Microbiology (miscellaneous)
- Clinical Neurology
Fingerprint Dive into the research topics of 'Inflammatory myopathies and human leukocyte antigen'. Together they form a unique fingerprint.
Cite this
Ohnuki, Y., Suzuki, S., & Shiina, T. (Accepted/In press). Inflammatory myopathies and human leukocyte antigen. Clinical and Experimental Neuroimmunology. https://doi.org/10.1111/cen3.12422